Proximyl Health, LLC – Trademark Portfolio
Entity Type: 16
Proximyl Health, LLC holds 6 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 35 (Advertising & Business) — 3 filings in this category. The portfolio also extends into Class 41 (Education & Entertainment) across 3 Nice Classification classes. Currently, 2 trademarks are registered. Notable registered marks include TECH SERUM and LIVING CREATIVE. The owner is based in Cranbury, NJ.
2 Clarke Drive
Cranbury, NJ 08512
Showing of trademarks Trademarks
Trademark Classifications
Proximyl Health, LLC's trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Advertising; business management; business administration; office functions
Education; providing of training; entertainment; sporting and cultural activities
Medical services; veterinary services; hygienic and beauty care for human beings or animals
Frequently Asked Questions
How many trademarks does Proximyl Health, LLC have?
Proximyl Health, LLC has 6 U.S. trademarks filed with the USPTO. Of these, 2 registered, 3 abandoned, 1 cancelled.
What trademark classes does Proximyl Health, LLC file in?
Proximyl Health, LLC files trademarks across 3 Nice Classification classes. The most active classes are Class 35 (Advertising & Business), Class 41 (Education & Entertainment), Class 44 (Medical Services). Class 35 covers advertising; business management; business administration; office functions.
What are Proximyl Health, LLC's most well-known trademarks?
Proximyl Health, LLC's registered trademark portfolio includes well-known marks such as TECH SERUM and LIVING CREATIVE. These are among 2 currently registered trademarks in the portfolio.
What is Proximyl Health, LLC's trademark registration success rate?
Proximyl Health, LLC has a 33% trademark registration rate, with 2 out of 6 resolved applications resulting in successful registration. Currently, 0 applications are pending review.